Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy
2021 ◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 575-575
◽
2014 ◽
Vol 18
(3)
◽
pp. 173-188
◽
2010 ◽
Vol 19
(sup1)
◽
pp. S31-S39
◽